ATRenew Inc. (every three of which representing two ) (Class A) (RERE) — RQD Stock Rating Cockpit

$3.90 -5.34% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $3.86

ATRenew Inc. (every three of which representing two ) (Class A) (RERE) carries a Roarable Rating of D- (Sell) with 39/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $903.4M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on RERE Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is RERE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, ATRenew Inc. (every three of which representing two ) (Class A) (NYSE: RERE) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $3.90 (-5.34% 1D, market cap $903.4M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 7/20. Across 1011 tracked Consumer Discretionary issuers, RERE ranks #748 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does RERE compare to WINA and WOOF in the Consumer Discretionary sector?
▼

Within the Consumer Discretionary sector (Other Specialty Stores), RERE carries a Roarable D- (39/100 RQD), trailing P/E of 18.8x, gross margin of —, and ROIC of 14.7%. By comparison, WINA (Winmark Corporation) holds a C grade (62/100 RQD, P/E 24.5x, ROIC 84.5%, cap $1.02B) and WOOF (Petco Health and Wellness Company Inc. (Class A)) posts a D- grade (43/100 RQD, P/E 81.5x, ROIC 4.0%, cap $741.8M). Among the 5-stock peer group, SPH leads on earnings multiple (11.2x) while WINA leads on capital efficiency (84.5% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for RERE?
▼

Per RERE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001838957), ATRenew Inc. (every three of which representing two ) (Class A) generated $0 in revenue, $48.1M in net income, and -$79.9M in free cash flow against $853.1M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $3.86 (-1.15%)🧬 Dilution Drag (+1.36% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (39/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.6% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • D-
025507510039
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Cash (8)Whales (9)SEC (10)Macro (5)CEO (7)
Each axis scored 0–20
12M PRICE TARGET CONE-8.5% Base Target
$7 Bull$4 Base$3 Bear
📬 FREE RERE RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for RERE)Realized 20D OHLCV Swing Band: ±7.2%
Deterministic 5-Pillar Attribution (39/100 Composite)
🔍 WHY RERE SCORES 39/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (26% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▲ #2 Bullish Driver: Whale & Options Positioning+9/20 pts (23% of score)

20D Institutional Volume Accumulation (±7.2% realized swing band)

▼ #1 Drag / Risk Factor: Macro Regime Fit5/20 pts (-15 pt drag)

Macro rate sensitivity & RSI-14 (57.9) create a -15 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
31
Grade E$3.73+4.8% Next Q
Q2 (-2Q)
34
Grade E$3.91+0.8% Next Q
Q3 (-1Q)
36
Grade E$3.94-1% Next Q
Current
39
Grade D-$3.90-7.6% Hist 90D α
Trajectory: E (31) → D- (39)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a RERE Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While RERE currently carries a cautious 39/100 (D-) rating due to Macro Regime Fit (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.94) and Max Pain ($4.10) forces dealer call-delta covering toward $6.79.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $RERE• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “RERE Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMBULLISH MOMENTUM
57.930 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREWEAK QUALITY (1–4)
3 / 99-Pt Accounting
52-WEEK LASER RANGE13% OF RANGE
L: $4$3.90H: $6
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: D-RQD 8 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 16 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D-RQD 15 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on RERE

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (40)

14.7% ROIC with 42.0% gross margin and -8.85% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BEARISH (50)

Altman-Z 4.20 and Piotroski 3/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (35)

16/40 institutional & smart-money positioning score with 5/20 macro alignment.

Bull Case: Why Buyers Like RERE
  • ✓Established market leader in Consumer Discretionary with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring RERE)

  • ✓Walkthrough of RERE's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
RERE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -9.72%▼ DESCENDING CHANNEL
2026-11-02O $3.96H $4.12L $3.90C $3.90VOL 463.6K
RES: $4.13SUP: $3.47SMA50: $3.94SMA200: $4.56
$5.32$4.83$4.33$3.84$3.35RES $4.13SUP $3.47$3.902026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

RERE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
12.1%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on RERE today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for RERE. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for RERE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (RERE)

Consumer Discretionary Rank #748 of 1011 ⚔️ WINA vs RERE Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (RERE vs. WINA, WOOF, SPH, REAL)

Industry: Other Specialty Stores (42 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, ATRenew Inc. (every three of which representing two ) (Class A) (RERE) ranks #748 by composite RQD confidence (39/100, grade D-) and #526 by equity capitalization ($903.4M). Within this direct 5-issuer industry benchmark cohort, SPH leads on earnings valuation at 11.2x trailing P/E, while WINA leads on capital efficiency and profitability with 84.5% ROIC and 96.0% gross margin. WINA currently holds the highest overall quantitative score in the immediate peer group at 62/100 (C) compared with RERE at 39/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
RERE ACTIVE
ATRenew Inc. (every three of which representing two ) (Class A)
D- 39/100 18.8x — 14.7% -5.34% $903.4M Benchmark Subject
WINA
Winmark Corporation
C 62/100 24.5x 96.0% 84.5% -0.41% $1.02B /wina-vs-rere →
WOOF
Petco Health and Wellness Company Inc. (Class A)
D- 43/100 81.5x 38.7% 4.0% +0.77% $741.8M /woof-vs-rere →
SPH
Suburban Propane Partners L.P.
D+ 54/100 11.2x 60.6% 8.4% +0.62% $1.19B /sph-vs-rere →
REAL
The RealReal Inc.
D- 39/100 — 74.6% -27.4% +5.37% $1.38B /real-vs-rere →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001838957

In its most recent audited fiscal period (FY2025, filed 2025-12-31), ATRenew Inc. (every three of which representing two ) (Class A) (RERE) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $48.1M, operating cash flow of -$59.3M, and free cash flow of -$79.9M (-200.1% YoY). On the balance sheet, RERE closed FY2025 with $853.1M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $0 $48.1M -$59.3M -$79.9M $853.1M —
FY2024 (FY) 2024-12-31 $0 -$1.1M $88.1M $79.9M $697.4M —
FY2023 (FY) 2023-12-31 $0 -$22.0M $34.4M $34.4M — —

3. RERE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is RERE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, ATRenew Inc. (every three of which representing two ) (Class A) (NYSE: RERE) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $3.90 (-5.34% 1D, market cap $903.4M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 7/20. Across 1011 tracked Consumer Discretionary issuers, RERE ranks #748 in composite RQD confidence.

How does RERE compare to WINA and WOOF in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Other Specialty Stores), RERE carries a Roarable D- (39/100 RQD), trailing P/E of 18.8x, gross margin of —, and ROIC of 14.7%. By comparison, WINA (Winmark Corporation) holds a C grade (62/100 RQD, P/E 24.5x, ROIC 84.5%, cap $1.02B) and WOOF (Petco Health and Wellness Company Inc. (Class A)) posts a D- grade (43/100 RQD, P/E 81.5x, ROIC 4.0%, cap $741.8M). Among the 5-stock peer group, SPH leads on earnings multiple (11.2x) while WINA leads on capital efficiency (84.5% ROIC).

What are the biggest fundamental strengths and SEC risk factors for RERE?

Per RERE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001838957), ATRenew Inc. (every three of which representing two ) (Class A) generated $0 in revenue, $48.1M in net income, and -$79.9M in free cash flow against $853.1M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is RERE trading relative to its 50-day, 200-day, and 52-week technical levels?

RERE last traded at $3.90 (-5.34% on volume of 395,134 shares), positioning the stock -1.02% below its 50-day simple moving average ($3.94) and -14.47% below its 200-day simple moving average ($4.56). Across its 52-week range of $3.50 to $6.47, RERE sits at the 13.5% percentile with a 14-day RSI of 57.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.2% ($3.62 to $4.18).

RERE Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell RERE stock right now?

ATRenew Inc. (every three of which representing two ) (Class A) (RERE) currently earns a Roarable Rating of D- (Sell — SELL) with 39/100 RQD Confidence. Stretched risk/reward at 19x P/E (15% return on capital) under elevated 10-year interest-rate pressure.

What is RERE's 12-month price target and RQD AI Jury consensus?

RERE's 12-month base price target is $3.57 (range $2.78 to $6.79), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

ROARABLE RATING BRIEF • RQD 39/100 (D-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

RERE — ATRenew Inc. (every three of which representing two ) (Class A): What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:31:59Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, RERE scores 39 out of 100 (letter grade D-), labeled "Roarable Sell — Vulnerable Balance Sheet & Flow." Across the five pillars: Fundamental Cash Engine 8/20 (ROIC 14.7%; FCF yield -8.85%); Whale 13F Flow 9/20 (institutional accumulation and options positioning); Insider Conviction 7/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit 5/20 (beta 1.0; sector sensitivity); Forensic Balance Sheet 10/20 (Altman Z 2.5; Piotroski F 3/9; Debt/Equity 0.5).

For a prospective investor, the pattern is a company with a respectable return on invested capital (14.7%) that is nonetheless not converting that into positive free cash flow (FCF yield -8.85%). The weakest pillar, Macro Regime Fit, reflects a beta of 1.0 and sector sensitivity, meaning the stock is expected to move in line with the broad market without a clear defensive offset. The Forensic Balance Sheet pillar is the strongest of the five but remains below midpoint, with a Piotroski F-Score of 3 out of 9 signaling weak fundamental quality. The upside case rests on the 14.7% ROIC and the trailing earnings profile (P/E TTM 18.8, forward P/E 17.5); the valuation tradeoff is that these multiples are not cheap relative to negative free cash flow. Whale and insider flow scores (9 and 7) indicate limited conviction signals in the current data.

Snapshot

MetricValue
Price4.12
Market Cap$903.4M
P/E (TTM)18.8
Forward P/E17.5
EV/EBITDA8.3
EPS (TTM)0.22
Dividend Yield0%
Beta1.0
52-Wk Range$3.5 - $6.47
ROIC %14.7%

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$0.0M$65.2M$48.1MN/A$-79.9M$219.9MN/A
FY 2024$0.0M$4.0M$-1.1MN/A$79.9M$269.9MN/A
FY 2023$0.0M$-24.4M$-22.0MN/A$34.4MN/AN/A

Per the SEC financials, operating income moved from $-24.4M in FY 2023 to $65.2M in FY 2025, and net income reached $48.1M in FY 2025 after $-1.1M in FY 2024. Per the market data, gross, operating, and net margins are each reported as 0%, so margin analysis cannot be reliably drawn from the source. ROIC is 14.7%. Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 3 of 9, and Debt/Equity is 0.5. FCF was $-79.9M in FY 2025 after $79.9M in FY 2024, and cash declined from $269.9M to $219.9M over that span.

Open Questions

  • What is driving the gap between positive FY 2025 net income ($48.1M) and negative FY 2025 free cash flow ($-79.9M)?
  • Why are reported revenue and all margins shown as 0%, and what revenue base underlies the earnings figures?
  • What is the debt level behind the Debt/Equity of 0.5, since debt is reported as N/A in every period?
  • What drove the decline in cash from $269.9M to $219.9M alongside the reversal in free cash flow?
  • What catalysts or institutional and insider activity, if any, are behind the 4.04% daily price change?

RERE Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for ATRenew Inc. (every three of which representing two ) (Class A) (RERE) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to RERE Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

RERE Bull vs. Bear Conversation Board — What's Your Call at $3.90?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON RERE 🐻 67% BEARISH CONVICTION
1. Pick Your Side on RERE:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $3.63 (-11.9%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is RERE (D- • RQD 39/100) a Buy at $4.12?

Welcome to the RERE (ATRenew Inc. (every three of which representing two ) (Class A)) Roar Pit. Current RQD Composite is 39/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Other Specialty Stores. Bulls point to capital efficiency (14.7% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

FO ForensicBear Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $3.13 (-24.0%)
Spot @ $4.12

Pump the brakes on RERE — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on RERE, but look at what you are paying: 18.8x trailing P/E with tightening sector spreads. Unless ATRenew Inc. (every three of which representing two ) (Class A) expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader 🐂 BULLISH 🎯 Target: $5.03 (+22.1%)
Spot @ $4.12

RERE cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on RERE, the market is fixating on short-term headline noise in Other Specialty Stores and ignoring the balance sheet and cash flow trajectory. At $4.12 (52-wk range $3.50 - $6.47), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%